• menu
    Market Place Market Place
    Sourcing SupportSourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    BLOG

    MARKET INTEL by PharmaCompass

    CONTENT by Suppliers

    News

    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.
    (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
    |
    Data Compilation #PharmaFlow (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide

    Top drugs and pharmaceutical companies of 2019 by revenues

    Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

    World looks for effective treatment to coronavirus, as drugmakers, regulators race ahead to find vaccines, cure

    Now that the World Health Organization (WHO) has declared the new coronavirus (2019-nCoV) as a publ

    Mysterious coronavirus outbreak may disrupt global drug supply chains

    The new coronavirus—named 2019-nCoV—has raised concerns across the world, and the repor

    Seven of your facilities are out of compliance, FDA tells Wockhardt; Mylan’s EpiPen sales crash

    In Phispers this week, there is news on how alternatives to Mylan’s EpiPen have eaten into it